Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”
In Brief: Karmanos Institute Names Four To Faculty; $1.5M Donated To Kaplan Cancer Center
In Congress: Senate Committee Approves 15% Increase For NCI In FY 1999; Report Urges NCI To Increase Research In Several Cancers
NCI Programs: Institute Seeks White Papers On Technology
Trending Stories
- “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process - DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
- How City of Hope is turning microbiome science into better cancer care
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - FDA clears fruit-flavored vapes, relaxes enforcement on black-market products with pending premarket applications
Critics say policies clear the way for major tobacco companies to enter fruit-flavored vape market - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members









